Based on the Central Nervous System (CNS) Stimulant Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Central Nervous System (CNS) Stimulant Drugs market covered in Chapter 5:
Ironshore Pharmaceuticals Inc.
Tris Pharma
GlaxoSmithKline PLC
Teva Pharmaceutical Industries Ltd.
Johnson & Johnson Services Inc.
Novartis AG
Pfizer Inc.
Shire
Lafon
In Chapter 6, on the basis of types, the Central Nervous System (CNS) Stimulant Drugs market from 2015 to 2025 is primarily split into:
Amphetamine
Metamfetamine
Dextroamphetamine
Pemoline
Methylphenidate
Others
In Chapter 7, on the basis of applications, the Central Nervous System (CNS) Stimulant Drugs market from 2015 to 2025 covers:
ADHD
Narcolepsy
Binge Eating Disorder
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Central Nervous System (CNS) Stimulant Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Ironshore Pharmaceuticals Inc.
5.1.1 Ironshore Pharmaceuticals Inc. Company Profile
5.1.2 Ironshore Pharmaceuticals Inc. Business Overview
5.1.3 Ironshore Pharmaceuticals Inc. Central Nervous System (CNS) Stimulant Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Ironshore Pharmaceuticals Inc. Central Nervous System (CNS) Stimulant Drugs Products Introduction
5.2 Tris Pharma
5.2.1 Tris Pharma Company Profile
5.2.2 Tris Pharma Business Overview
5.2.3 Tris Pharma Central Nervous System (CNS) Stimulant Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Tris Pharma Central Nervous System (CNS) Stimulant Drugs Products Introduction
5.3 GlaxoSmithKline PLC
5.3.1 GlaxoSmithKline PLC Company Profile
5.3.2 GlaxoSmithKline PLC Business Overview
5.3.3 GlaxoSmithKline PLC Central Nervous System (CNS) Stimulant Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 GlaxoSmithKline PLC Central Nervous System (CNS) Stimulant Drugs Products Introduction
5.4 Teva Pharmaceutical Industries Ltd.
5.4.1 Teva Pharmaceutical Industries Ltd. Company Profile
5.4.2 Teva Pharmaceutical Industries Ltd. Business Overview
5.4.3 Teva Pharmaceutical Industries Ltd. Central Nervous System (CNS) Stimulant Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Teva Pharmaceutical Industries Ltd. Central Nervous System (CNS) Stimulant Drugs Products Introduction
5.5 Johnson & Johnson Services Inc.
5.5.1 Johnson & Johnson Services Inc. Company Profile
5.5.2 Johnson & Johnson Services Inc. Business Overview
5.5.3 Johnson & Johnson Services Inc. Central Nervous System (CNS) Stimulant Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Johnson & Johnson Services Inc. Central Nervous System (CNS) Stimulant Drugs Products Introduction
5.6 Novartis AG
5.6.1 Novartis AG Company Profile
5.6.2 Novartis AG Business Overview
5.6.3 Novartis AG Central Nervous System (CNS) Stimulant Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Novartis AG Central Nervous System (CNS) Stimulant Drugs Products Introduction
5.7 Pfizer Inc.
5.7.1 Pfizer Inc. Company Profile
5.7.2 Pfizer Inc. Business Overview
5.7.3 Pfizer Inc. Central Nervous System (CNS) Stimulant Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Pfizer Inc. Central Nervous System (CNS) Stimulant Drugs Products Introduction
5.8 Shire
5.8.1 Shire Company Profile
5.8.2 Shire Business Overview
5.8.3 Shire Central Nervous System (CNS) Stimulant Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Shire Central Nervous System (CNS) Stimulant Drugs Products Introduction
5.9 Lafon
5.9.1 Lafon Company Profile
5.9.2 Lafon Business Overview
5.9.3 Lafon Central Nervous System (CNS) Stimulant Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Lafon Central Nervous System (CNS) Stimulant Drugs Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Central Nervous System (CNS) Stimulant Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Central Nervous System (CNS) Stimulant Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Central Nervous System (CNS) Stimulant Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Central Nervous System (CNS) Stimulant Drugs Price by Types (2015-2020)
6.2 Global Central Nervous System (CNS) Stimulant Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Central Nervous System (CNS) Stimulant Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Central Nervous System (CNS) Stimulant Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Central Nervous System (CNS) Stimulant Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Central Nervous System (CNS) Stimulant Drugs Sales, Price and Growth Rate of Amphetamine
6.3.2 Global Central Nervous System (CNS) Stimulant Drugs Sales, Price and Growth Rate of Metamfetamine
6.3.3 Global Central Nervous System (CNS) Stimulant Drugs Sales, Price and Growth Rate of Dextroamphetamine
6.3.4 Global Central Nervous System (CNS) Stimulant Drugs Sales, Price and Growth Rate of Pemoline
6.3.5 Global Central Nervous System (CNS) Stimulant Drugs Sales, Price and Growth Rate of Methylphenidate
6.3.6 Global Central Nervous System (CNS) Stimulant Drugs Sales, Price and Growth Rate of Others
6.4 Global Central Nervous System (CNS) Stimulant Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Amphetamine Market Revenue and Sales Forecast (2020-2025)
6.4.2 Metamfetamine Market Revenue and Sales Forecast (2020-2025)
6.4.3 Dextroamphetamine Market Revenue and Sales Forecast (2020-2025)
6.4.4 Pemoline Market Revenue and Sales Forecast (2020-2025)
6.4.5 Methylphenidate Market Revenue and Sales Forecast (2020-2025)
6.4.6 Others Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Central Nervous System (CNS) Stimulant Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Central Nervous System (CNS) Stimulant Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Central Nervous System (CNS) Stimulant Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Central Nervous System (CNS) Stimulant Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Central Nervous System (CNS) Stimulant Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Central Nervous System (CNS) Stimulant Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Central Nervous System (CNS) Stimulant Drugs Revenue, Sales and Growth Rate of ADHD (2015-2020)
7.3.2 Global Central Nervous System (CNS) Stimulant Drugs Revenue, Sales and Growth Rate of Narcolepsy (2015-2020)
7.3.3 Global Central Nervous System (CNS) Stimulant Drugs Revenue, Sales and Growth Rate of Binge Eating Disorder (2015-2020)
7.3.4 Global Central Nervous System (CNS) Stimulant Drugs Revenue, Sales and Growth Rate of Others (2015-2020)
7.4 Global Central Nervous System (CNS) Stimulant Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 ADHD Market Revenue and Sales Forecast (2020-2025)
7.4.2 Narcolepsy Market Revenue and Sales Forecast (2020-2025)
7.4.3 Binge Eating Disorder Market Revenue and Sales Forecast (2020-2025)
7.4.4 Others Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Central Nervous System (CNS) Stimulant Drugs Sales by Regions (2015-2020)
8.2 Global Central Nervous System (CNS) Stimulant Drugs Market Revenue by Regions (2015-2020)
8.3 Global Central Nervous System (CNS) Stimulant Drugs Market Forecast by Regions (2020-2025)
9 North America Central Nervous System (CNS) Stimulant Drugs Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Central Nervous System (CNS) Stimulant Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Central Nervous System (CNS) Stimulant Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Central Nervous System (CNS) Stimulant Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Central Nervous System (CNS) Stimulant Drugs Market Analysis by Country
9.6.1 U.S. Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
9.6.2 Canada Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
9.6.3 Mexico Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
10 Europe Central Nervous System (CNS) Stimulant Drugs Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Central Nervous System (CNS) Stimulant Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Central Nervous System (CNS) Stimulant Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Central Nervous System (CNS) Stimulant Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Central Nervous System (CNS) Stimulant Drugs Market Analysis by Country
10.6.1 Germany Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
10.6.2 United Kingdom Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
10.6.3 France Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
10.6.4 Italy Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
10.6.5 Spain Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
10.6.6 Russia Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
11 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Central Nervous System (CNS) Stimulant Drugs Market Analysis by Country
11.6.1 China Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
11.6.2 Japan Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
11.6.3 South Korea Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
11.6.4 Australia Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
11.6.5 India Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
12 South America Central Nervous System (CNS) Stimulant Drugs Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Central Nervous System (CNS) Stimulant Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Central Nervous System (CNS) Stimulant Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Central Nervous System (CNS) Stimulant Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Central Nervous System (CNS) Stimulant Drugs Market Analysis by Country
12.6.1 Brazil Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
12.6.2 Argentina Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
12.6.3 Columbia Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
13 Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Central Nervous System (CNS) Stimulant Drugs Market Analysis by Country
13.6.1 UAE Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
13.6.2 Egypt Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
13.6.3 South Africa Central Nervous System (CNS) Stimulant Drugs Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Central Nervous System (CNS) Stimulant Drugs Market Size and Growth Rate 2015-2025
Table Central Nervous System (CNS) Stimulant Drugs Key Market Segments
Figure Global Central Nervous System (CNS) Stimulant Drugs Market Revenue ($) Segment by Type from 2015-2020
Figure Global Central Nervous System (CNS) Stimulant Drugs Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Central Nervous System (CNS) Stimulant Drugs
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Ironshore Pharmaceuticals Inc. Company Profile
Table Ironshore Pharmaceuticals Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Ironshore Pharmaceuticals Inc. Production and Growth Rate
Figure Ironshore Pharmaceuticals Inc. Market Revenue ($) Market Share 2015-2020
Table Tris Pharma Company Profile
Table Tris Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Tris Pharma Production and Growth Rate
Figure Tris Pharma Market Revenue ($) Market Share 2015-2020
Table GlaxoSmithKline PLC Company Profile
Table GlaxoSmithKline PLC Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GlaxoSmithKline PLC Production and Growth Rate
Summary: Get latest Market Research Reports on Central Nervous System (CNS) Stimulant Drugs. Industry analysis & Market Report on Central Nervous System (CNS) Stimulant Drugs is a syndicated market report, published as Global Central Nervous System (CNS) Stimulant Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Central Nervous System (CNS) Stimulant Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.